Literature DB >> 30685402

Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats.

Ana Beatriz Sant'Ana1, Heloisa Helena Vilela-Costa1, Maria Adrielle Vicente1, Paloma Molina Hernandes1, Telma Gonçalves Carneiro Spera de Andrade2, Hélio Zangrossi3.   

Abstract

The role of 5-HT2C receptors (5-HT2CRs) in the regulation of anxiety has been widely acknowledged. However, conflicting results have been reported on whether stimulation of these receptors increases or decreases anxiety. We here investigated the role of 5-HT2CRs of the dorsal hippocampus (DH) in the mediation of anxiety- or panic-associated defensive behaviors and in the anxiolytic effect of the tricyclic antidepressant imipramine. In the Vogel conflict test, administration of the mixed 5-HT2CR agonist mCPP into the DH of male Wistar rats was anxiogenic, whereas infusions of the more selective agonists MK-212 and RO-600175 were anxiolytic. The 5-HT2CR antagonist SB-242084, on the other hand, was anxiogenic. A sub-effective dose of this antagonist blocked the anxiolytic effect of RO-600175, but not the increase in anxiety observed with mCPP, indicating that the latter effect was not due to 5-HT2CR activation. In full agreement with these findings, MK-212 and RO-600175 in the DH also inhibited inhibitory avoidance acquisition in the elevated T-maze, whereas SB-242084 caused the opposite effect. None of these drugs interfered with escape expression in this test, which has been associated with panic. Chronic administration of imipramine (15 mg/kg, ip, 21 days) caused an anxiolytic effect in the elevated T-maze and light-dark transition tests, which was not blocked by previous infusion of SB-242084 into the DH. Therefore, facilitation of 5-HT2CR-mediated neurotransmission in the DH decreases the expression of anxiety-, but not panic-related defensive behaviors. This mechanism, however, is not involved in the anxiolytic effect caused by imipramine.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5-HT2C receptor; Anxiety; Dorsal hippocampus; Elevated T-maze; Imipramine; Serotonin

Mesh:

Substances:

Year:  2019        PMID: 30685402     DOI: 10.1016/j.neuropharm.2019.01.026

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Contribution of Corticotropin-Releasing Factor Receptor 1 (CRF1) to Serotonin Receptor 5-HT2CR Function in Amygdala Neurons in a Neuropathic Pain Model.

Authors:  Guangchen Ji; Volker Neugebauer
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

Review 2.  Effect of Estrous Cycle on Behavior of Females in Rodent Tests of Anxiety.

Authors:  Thelma A Lovick; Hélio Zangrossi
Journal:  Front Psychiatry       Date:  2021-08-31       Impact factor: 4.157

Review 3.  Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.

Authors:  Mark J Millan
Journal:  Ther Adv Psychopharmacol       Date:  2022-06-30

4.  Effects of Jian-Pi-Zhi-Dong Decoction on the Expression of 5-HT and Its Receptor in a Rat Model of Tourette Syndrome and Comorbid Anxiety.

Authors:  Dan Wang; Hui-Ling Tian; Xia Cui; Qian Wang; Fan Guo; Wen Zhang; Qi-Sheng Tang
Journal:  Med Sci Monit       Date:  2020-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.